and careful assessment of congestion pre-discharge (2, 3) . This includes assessing signs and symptoms and performing a chest radiograph, but the sensitivity and specificity of these methods to accurately estimate congestion are limited (4) . Unfortunately, standardized metrics or (de)congestion scores are currently lacking. Several papers were recently published on multiple surrogates used to assess decongestion during hospitalization for acute heart failure. A frequently described surrogate is a rise in hemoglobin during a heart failure admission, indicated as hemoconcentration. Three large studies showed that hemoconcentration was associated with greater weight and fluid loss, greater reductions in filling pressures, and less residual congestion (5-7). A consistent finding among these 3 trials was a clear association between a greater hemoconcentration and a reduction in early post-discharge events and heart failure readmission in particular.
Diuretic response during hospitalization was recently proposed as another surrogate for decongestion (8) (9) (10) . A good diuretic response was associated with greater weight and fluid loss and less use of inotropes during hospitalization. Moreover, diuretic response was strongly and independently associated with a reduction in early post-discharge events and lower rates of heart failure rehospitalization. These 2 examples illustrate that an indirect metric to establish decongestion might be of great value during hospitalization, either to guide therapy or for its prognostic value. However, these metrics were applied during the in-hospital phase, but data on assessment or mea- From the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Both authors have reported that they have no relationships relevant to the contents of this paper to disclose.
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In clinical practice, we are all confronted with the heart failure patients indicated as "frequent flyers."
These patients are hospitalized for acute decompensated heart failure, discharged, and rehospitalized within days to weeks after discharge. It remains difficult to accurately predict which patients are at risk, because the reasons for this are multifactorial. The social situation, treatment adherence, disease progression, and many other factors play a role. Therefore, the prediction of heart failure rehospitalization is notoriously more difficult than the prediction of (cardiovascular) mortality. The present study indicates that relative plasma volume status, calculated from weight and hematocrit, has a reasonable correlation with measured plasma volume in healthy volunteers (r ¼ 0.68; p < 0.001) and in outpatients with chronic heart failure (r ¼ 0.51; p < 0.001) (12) . This study also found that higher relative plasma volume status was associated with the occurrence of death and heart failure hospitalization in stable chronic heart failure patients. To the best of our knowledge, this study is the first to study the use of estimated plasma volume shortly after admission. This proposed metric is a readily applicable and easy accessible tool to assess congestion status and could be used after discharge. 
